Intercept Drug’s Market Standing In PBC Undermined By Safety Woes

Ocaliva Now Contraindicated In Advanced Cirrhosis

 
• By Joseph Haas
  
liver
Two FDA safety updates for PBC drug Ocaliva could threaten its market standing
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business